The estimated Net Worth of Thaddeus Henry Jr Grasela is at least $13.6 Milion dollars as of 18 May 2017. Thaddeus Grasela owns over 37,031 units of Simulations Plus stock worth over $12,885,537 and over the last 8 years he sold SLP stock worth over $430,671. In addition, he makes $297,500 as Senior Advisory Capacity at Simulations Plus.
Sign up
Thaddeus Grasela SLP stock SEC Form 4 insiders trading
Thaddeus has made over 1 trades of the Simulations Plus stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 37,031 units of SLP stock worth $430,671 on 18 May 2017.
The largest trade he's ever made was selling 37,031 units of Simulations Plus stock on 18 May 2017 worth over $430,671. On average, Thaddeus trades about 1,949 units every 0 days since 2016. As of 18 May 2017 he still owns at least 392,732 units of Simulations Plus stock.
You can see the complete history of Thaddeus Grasela stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thaddeus Grasela biography
Dr. Thaddeus Henry Grasela Jr. Ph.D. serves as Senior Advisory Capacity of the Company. Dr. Grasela was the founder, President and Chief Executive Officer of Cognigen for 22 years prior to the acquisition and served as its President until September 2019. Dr. Grasela has had extensive experience in the strategic oversight of scientific consulting projects, promoting new revenue generation, managing profitability, and overseeing the growth of the organization. Dr. Grasela is a Fellow of the American Association of Pharmaceutical Scientists and Adjunct Professor in the Department of Pharmaceutical Sciences at the State University of New York at Buffalo. Dr. Grasela received his PharmD in 1979 from the Philadelphia College of Pharmacy and Science and his doctorate in Epidemiology from the University at Buffalo in 1999.
What is the salary of Thaddeus Grasela?
As the Senior Advisory Capacity of Simulations Plus, the total compensation of Thaddeus Grasela at Simulations Plus is $297,500. There are 5 executives at Simulations Plus getting paid more, with Shawn M. O'Connor having the highest compensation of $544,231.
How old is Thaddeus Grasela?
Thaddeus Grasela is 65, he's been the Senior Advisory Capacity of Simulations Plus since 2019. There are 5 older and 9 younger executives at Simulations Plus. The oldest executive at Simulations Plus Inc. is Walter S. Woltosz M.A.S., M.S., 76, who is the Co-Founder & Chairman.
What's Thaddeus Grasela's mailing address?
Thaddeus's mailing address filed with the SEC is 1780 WEHRLE DRIVE SUITE 110, , BUFFALO, NY, 14221.
Insiders trading at Simulations Plus
Over the last 21 years, insiders at Simulations Plus have traded over $70,055,940 worth of Simulations Plus stock and bought 24,000 units worth $1,395,840 . The most active insiders traders include Walter Swoltosz Virginia E ..., Walter S Woltosz oraz Momoko A Beran. On average, Simulations Plus executives and independent directors trade stock every 37 days with the average trade being worth of $571,025. The most recent stock trade was executed by Jill Fiedler Kelly on 9 September 2024, trading 2,250 units of SLP stock currently worth $21,848.
What does Simulations Plus do?
simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. with our subsidiaries, cognigen corporation and dilisym services, we offer #1-ranked, easy-to-use software (gastroplus™, admet predictor™, kiwi™, dilisym®, nafldsym®, pkplus™, and more) to bridge data mining, compound library screening with qsar models, pbpk/tk modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. simulations plus technology is licensed to and used by regulatory agencies worldwide. for over 20 years, simulations plus has partnered with our clients to reduce costs and accelerate res
What does Simulations Plus's logo look like?
Complete history of Thaddeus Grasela stock trades at Simulations Plus
Simulations Plus executives and stock owners
Simulations Plus executives and other stock owners filed with the SEC include:
-
Shawn M. O'Connor,
Chief Exec. Officer -
Shawn O'Connor,
Chief Executive Officer -
William Frederick,
CFO & Sec. -
John DiBella,
President, Lancaster Division -
John Anthony DiBella M.S.,
Pres of Lancaster Division -
Thaddeus Grasela,
Senior Advisory Capacity -
John Kneisel,
Chief Financial Officer -
Jill Fiedler-Kelly M.S., MS,
Pres of Cognigen Division -
Dr. Brett A. Howell Ph.D.,
Pres of DILIsym Services, Inc -
Dr. Brett A. Howell,
Pres of DILIsym Services, Inc -
John Paglia,
Independent Director -
Daniel Weiner,
Independent Director -
David Ralph,
Independent Director -
Walter Woltosz,
Chairman of the Board -
Walter S. Woltosz M.A.S., M.S.,
Co-Founder & Chairman -
Lisa LaVange,
Independent Director -
Renee Bouche,
IR Contact Officer -
Jill Fiedler-Kelly,
President - Cognigen division -
Dr. Scott Q. Siler,
Chief Scientific Officer of DILIsym Services, Inc -
Lindsay Luke,
Exec. Director of HR -
Arlene Padron,
Corp. Director of Marketing -
Viera Lukacova Ph.D.,
Chief Scientific Officer -
Argenio David Z D,
Director -
Brett Howell,
Business Unit President -
Steven Chang,
President, Immunetrics -
William W Frederick,
CFO -
Walter Swoltosz Virginia E ...,
-
Walter S Woltosz,
Director -
Richard R Weiss,
Director -
Momoko A Beran,
Chief Financial Officer -
Harold Wayne Rosenberger,
Director -
Jeffrey A Dahlen,
VP, Research & Development -
Virginia E Woltosz,
Secretary/Treasurer -
Ronald F Creeley,
VP Marketing & Sales -
Daniel Szot,
Chief Revenue Officer -
Sharlene Evans,
Director